Elawyers Elawyers
Washington| Change

Infuturia Global Ltd. v. SEQUUS PHARMACEUTICALS, 09-16378 (2011)

Court: Court of Appeals for the Ninth Circuit Number: 09-16378 Visitors: 4
Filed: Feb. 07, 2011
Latest Update: Feb. 21, 2020
Summary: FILED NOT FOR PUBLICATION FEB 07 2011 MOLLY C. DWYER, CLERK UNITED STATES COURT OF APPEALS U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT INFUTURIA GLOBAL LTD., No. 09-16378 Plaintiff - Appellant, D.C. No. 4:08-cv-04871-SBA v. MEMORANDUM* SEQUUS PHARMACEUTICALS, INC.; et al., Defendants - Appellees. Appeal from the United States District Court for the Northern District of California Saundra B. Armstrong, District Judge, Presiding Argued August 31, 2010 Submitted January 31, 2011 Pocatello, Idaho Be
More
                                                                                      FILED
                                NOT FOR PUBLICATION                                    FEB 07 2011

                                                                                   MOLLY C. DWYER, CLERK
                        UNITED STATES COURT OF APPEALS                              U.S. COURT OF APPEALS



                                FOR THE NINTH CIRCUIT


 INFUTURIA GLOBAL LTD.,                                  No. 09-16378

                 Plaintiff - Appellant,                  D.C. No. 4:08-cv-04871-SBA

   v.
                                                         MEMORANDUM*
 SEQUUS PHARMACEUTICALS, INC.;
 et al.,

                 Defendants - Appellees.


                      Appeal from the United States District Court
                         for the Northern District of California
                     Saundra B. Armstrong, District Judge, Presiding

                                  Argued August 31, 2010
                                 Submitted January 31, 2011
                                     Pocatello, Idaho

Before: BYBEE, TYMKOVICH,** and N.R. SMITH, Circuit Judges.

        Infuturia Global Ltd. (“Infuturia”) appeals the district court’s order

dismissing its Second Amended Complaint under Federal Rules of Civil Procedure




        *
            This disposition is not appropriate for publication and is not precedent except as
provided by 9th Cir. R. 36-3.
        **
            The Honorable Timothy M. Tymkovich, United States Circuit Judge for the Tenth
Circuit, sitting by designation.
12(b)(6) and 12(b)(7). This court has jurisdiction pursuant to 28 U.S.C. § 1291.

We affirm.

      The district court did not err in dismissing this case under Federal Rule of

Civil Procedure 12(b)(6), because Infuturia did not allege sufficient facts “to state a

claim to relief that is plausible on its face.” Bell Atl. Corp. v. Twombly, 
550 U.S. 544
, 570 (2007). On the tortious interference claim, Infuturia failed to allege

damages stemming from Sequus’s conduct, which is one of the required elements

of a tortious interference claim under California law. See Pac. Gas & Elec. Co. v.

Bear Sterns & Co., 
50 Cal. 3d 1118
, 1126 (Cal. 1990). Finding the First Amended

Complaint deficient, the district court ordered Infuturia to identify “the Sequus

products—particular compounds, pharmaceutical compositions, improvements,

developments, inventions, etc.—that allegedly fall within the scope of Infuturia’s

purported contractual rights . . . .” Although Infuturia’s Second Amended

Complaint refers generally to lost profits, it failed to identify any particular

product, compound, or invention that causes Infuturia to lose profits and royalties.

      Similarly, on the conversion claim, Infuturia failed to explain how Sequus

perpetrated an “act of dominion wrongfully asserted over [Infuturia]’s personal

property in denial of or inconsistent with [its] rights therein.” In re Bailey, 
197 F.3d 997
, 1000 (9th Cir. 1999) (citation and quotation marks omitted). As with the


                                            2
tortious interference claim, Infuturia did not identify a particular product,

compound, or invention from Sequus that interfered with Infuturia’s licensing

rights to certain Yissum patents.

      Finally, the district court did not abuse its discretion by denying Infuturia’s

claims with prejudice. Leave to amend “need not be granted where the amendment

of the complaint would cause the opposing party undue prejudice, is sought in bad

faith, constitutes an exercise in futility, or creates undue delay.” Ascon Props., Inc.

v. Mobil Oil Co., 
866 F.2d 1149
, 1160 (9th Cir. 1989) (citation omitted). “The

district court’s discretion to deny leave to amend is particularly broad where

plaintiff has previously amended the complaint.” 
Id. (citation omitted).
Here,

Infuturia had two opportunities to amend its complaint. Notwithstanding the

district court’s specific instructions regarding the prior complaints’ deficiencies,

Infuturia’s Second Amended Complaint failed to make out a plausible claim.

      Finally, we GRANT Infuturia’s Motion to Take Judicial Notice in Support

of Supplemental Brief of Appellant, Docket No. 33.

      AFFIRMED.




                                            3

Source:  CourtListener

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer